Le Lézard
Classified in: Health, Business
Subject: CXP

Select Medical Launches ReVital Cancer Rehabilitation Program in Central Pennsylvania


MECHANICSBURG, Pa., Oct. 7, 2019 /PRNewswire/ -- Select Medical today announced that its ReVitaltm cancer rehabilitation program is now available in Central Pennsylvania spanning Harrisburg, Mechanicsburg, Hershey, York, Hanover and Lancaster. Thirteen centers owned or managed by Select Physical Therapy across the region began providing cancer therapy services to patients last week.   

ReVital is an innovative rehabilitation program that helps those affected by cancer and its treatments to achieve comprehensive recovery through physical and occupational therapy, speech-language pathology, and cognitive rehabilitation. The evidence-based program enables patients to live well beyond cancer by addressing pain, fatigue, numbness, swelling, cognitive decline and many other cancer-related side effects.

Sixty percent of all people affected by cancer have at least one physical or functional issue as a result of their cancer treatment, according to articles published in the Journal of Clinical Oncology.  In addition, 25 to 60 percent experience lasting pain, while 80 to 90 percent deal with cancer-related fatigue. And yet, cancer rehabilitation services are extremely underutilized, according to research published in the Journal of Geriatric Oncology and the Journal of Clinical Oncology.

"We are delighted to bring the groundbreaking ReVital program to the Central Pennsylvania region," said Dr. Michael D. Stubblefield, national medical director, ReVital Cancer Rehabilitation, Select Medical. "Our therapists are empowering patients to live their best lives by maximizing function so they are able to return to their families, jobs and other life priorities. We are defining the standard of care for cancer survivors."  

To date, more than 600 Select Medical therapists are ReVital-certified, completing a comprehensive oncology rehabilitation education program guided by the nation's latest best practices. The program currently serves patients in more than 300 locations across the U.S. and continues to grow.  

For more information about ReVital and its center locations, visit: www.revitalcancerrehab.com.

About Select Medical
Select Medical is one of the largest operators of critical illness recovery hospitals (previously referred to as long term acute care hospitals), rehabilitation hospitals (previously referred to as inpatient rehabilitation facilities), outpatient rehabilitation clinics, and occupational health centers in the United States based on the number of facilities. As of June 30, 2019, Select Medical had operations in 47 states and the District of Columbia. Select Medical operated 100 critical illness recovery hospitals in 28 states, 28 rehabilitation hospitals in 12 states, and 1,695 outpatient rehabilitation clinics in 37 states and the District of Columbia. Concentra, a joint venture subsidiary, operated 526 occupational health centers in 41 states as of June 30, 2019. Concentra also provides contract services at employer worksites and Department of Veterans Affairs community-based outpatient clinics. Information about Select Medical is available at www.selectmedical.com.

Media Contact
Shelly Eckenroth, [email protected] or 717-920-4035

SOURCE Select Medical


These press releases may also interest you

at 00:25
Shanghai Junshi Biosciences Co., Ltd ("Junshi Biosciences," HKEX: 1877; SSE: 688180), a leading innovation-driven biopharmaceutical company dedicated to the discovery, development, and commercialization of novel therapies, announced its financial...

28 mar 2024
The report titled "Central Lab Market by Service Type (Anatomic Pathology/Histology, Biomarker Services, Genetic Services), Phase (Phase 1, Phase 2, Phase 3), Therapeutic Area, End-use - Global Forecast 2024-2030" is now available on...

28 mar 2024
The report titled "Personalized Nutrition Market by Measurement Type (Active Measurement, Standard Measurement), Application (Indication-based, Standard Supplements), Distribution Channel, End-Use - Global Forecast 2024-2030" is now available on...

28 mar 2024
The report titled "Carbon Dioxide Incubator Market by Product (Air Jacketed CO2 Incubators, Direct Heat CO2 Incubators, Water Jacketed CO2 Incubators), Capacity (100-200 Litre, Above 200 Litre, Below 100 Litre), Application, End User - Global...

28 mar 2024
The "Global Clinical In Vitro Diagnostic Medical Laboratory Services Market: Strategy & Trends with Volume & Price Forecasts by Chemistry, Hematology, Microbiology, Pathology, Covid-19, and Molecular Dx by Country. Updated with Impact of COVID-19"...

28 mar 2024
The "Molecular Diagnostics at the Point of Care. By Application, Technology, Place, Product and by Country. With Executive Guides and Customization 2023 - 2027 " report has been added to  ResearchAndMarkets.com's offering. Infectious disease Dx is...



News published on and distributed by: